MR-linac Guided Ultra-hypofractionated RT for Prostate Cancer (SMART-P01 and SMART-P02)

NCT05183074 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer
Radiotherapy Side Effect
Magnetic Resonance-linac
Stereotactic Ablative RT
Adaptive Radiotherapy
Localised Disease
Oligometastatic Disease

Interventions

DEVICE: MR-linac

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences